HERE ARE ALL REASON WHY BMSN WILL SURPASS AMB$ READ BELOW!!
FDA APPROVAL CAN COME AT ANY MOMENT!
"On June 21, 2013, we received a second set of FDA comments stating several of their questions were adequately addressed, however additional data needs to be submitted"
They already assembled a team that has generated the required data. Not that it is being generated. But, that it is generated. Given that they did what was required to complete the trademark and not pull it from the process coupled with the data being generated the approval and subsequent trials for this Orphan Drug can start any time!
90% of all start up companies biotech or not reports -O- income. Why would they have a revenue stream with no product? Once they have a marketable FDA approved product then they can attract big pharma to buy them out! I never heard of any start-up penny stock company making millions of dollars in revenue with no product! There will be a drastic change in PPS this July as FDA response is expected to come any day now that will initiate clinical trials on humans.
FDA CLINICAL TRIAL INITIATION IS IMMINENT DON'T GET LEFT BEHIND!
Lawsuits? All BMSN Lawsuit have been resolved! Case close! Not wanted for federal questioning! Those lawsuit were meaningless! C'mon a shell company that has no asset's nor product try's to cash in on BMSN!! Lawsuits happen all the time in every company! Not all claims are legit!
Look at StarCity capital LLC. with no executives or employees! BWhahahahahahaha!! StarCity capital was just looking for a quick payday!! Its equilavent to some sueing Mcdonalds for coffee that's too hot when they clearly ordered hot coffee!! lmao
(Most Recent- Settled) Lawsuit Filed April 12, 2013
1. On January 2, 2013, Starcity exercised its right to convert $17,000 of its debt into 103,030,303 shares of BMSN (the “Conversion Notice”). The Conversion Notice took advantage of extraordinarily low public market prices of BMSN common stock, as was Starcity’s right under the STA. The next day, on January 3, 2013, Defendants, as they were required to do,
Between January 2, 2013 and February 27, 2013, Defendants, with the intent to prefer their own personal and other stockholders’ stock positions ahead of Starcity’s lawful stockholder position in BMSN, and to the knowing detriment of Starcity, used false promises and deception to trick Starcity into surrendering its Starcity BMSN Stock Certificate based on the false promise that such shares promptly would be transmitted electronically to Starcity’s brokerage account via DWAC. For weeks after Starcity surrendered its Starcity BMSN Stock Certificate, and while the price of BMSN stock was trading at similar very low prices, Defendants continuously and falsely reassured Starcity that such DWACtransmission would be made promptly. All the while, Defendants, and each of them, knew that Defendants intended to construe the surrendering of such Starcity ...ons ahead of Starcity’s lawful stockholder position in BMSN.
NOW THAT THESE Starcity FOOLS SOLD ALL THEIR BMSN TICKETS UP WE GO! THAT WAS THE LAST LAWSUIT WHICH HAS BEEN RESOLVED!! Here are the other two which OLD and RESOLVED!!!
2. SETTLEMENT AGREEMENT Parties: BIO-MATRIX SCIENTIFIC GROUP, INC. | 18 KTTV, LLC | BIO-MATRIX SCIENTIFIC GROUP, INC Document Date: 3/12/2013 Industry: Medical Equipment and Supplies Sector: Healthcare Governing Law:Pennsylvania
THESE LAWSUITS ARE SO BORING AND IRREVELANT TO FDA APPROVAL! EVERY COMPANY WITH A LEGIMATE SERVICE OR PRODUCT IS EXPOSED TO LAWSUITS! BIG DEAL!! CASE RESOLVED!! IN ADDITION THEY ARE ALL OLD! YAWN!!
When new penny stock share issues are a good thing:
Legal battles: Smaller companies often find themselves in costly legal battles with much bigger players. For example, many tech companies must go to court to enforce patents rights. To pay legal fees, companies may issue shares for general working capital purposes. When the company is on the right side of a legal battle, it can be beneficial for them and shareholders to dilute in order to litigate.
The O/S is maxed out!! Dilution is over!
Here is an example of Oustanding shares and its impact!
Comparison of stocks - shares outstanding:
Intel (INTC) - 5.52 billion shares outstanding
Texas Instruments (TXN) - 1.24 billion shares outstanding (23% of Intel's # of shares)
Analog Devices (ADI) - 297.69 million shares outstanding (5% of Intel)
STMicroelectronics (STM) - 878.32 million shares outstanding (16% of Intel)
Advanced Micro Devices (AMD) - 672.13 million shares outstanding (12% of Intel)
Share stability and volatility: A greater number of shares outstanding can also support the claim that a company has greater price stability, given that it takes many more shares traded to create a significant percentage movement in the stock. Contrary to this, the stock with a much lower number of outstanding shares, like ADI above, representing only 5% of Intel's total, could be more vulnerable to price manipulation, requiring much fewer shares to be traded up or down to move the stock price.
These BMSN Short Numbers are ridiculously low! Its getting harder and harder to get shares!!
BMSN has accomplished so much and has even been featured on NBC NEWS!! Know what you hold! There is plenty of DD out there! These shares are more precious than gold right now! Treat it as such and enjoy the ride north!! We have a strong chance of hitting .007 today!! http://www.nbcnews.com/id/51786808#.UZFZQIy9KSM (Link is expired due to NBC featured news time frame)
Oncology Innovations Some of biggest innovations have been in the field of oncology. The actress Angelina Jolie recently became the new face of breast cancer, after announcing that she’d had a double-mastectomy upon discovering that she carried a gene that predicts about a 60 percent chance of developing the disease.
Thanks to the advances in genetic screening, drug developers also now look for genetic mutations in tumors that can explain why they grow and metastasize, and create drugs to specifically target that aspect of the disease.
Surely BMSN will save lives and eliminate the budden of a mastectomy! Breast cancer gene silicensing technology will do just that!!
Lets just say that the FDA has 30days to respond which I highly doubt it would take that long cause they already have BMSN information filed on their system! We should be hearing a verdict by Mid July the latest! But realisticly a response from FDA can come with 2-3 weeks considering that the response is mailed!
"We are pleased with the responses that we have provided to the FDA and look forward to initiating our clinical trials," stated David Koos, Chairman and CEO of Regen BioPharma. "Although it is possible that a second round of comments may be issued, we feel this process is extremely useful to creating a clinical trial that is optimized for safety and detection of efficacy."
This is not a 1 day flip! If your looking for that please exit left! There are plenty of BS pump and dumps out there! BMSN is a long term hold! The clock for FDA response started JUNE 7, 2013! They have 30 days to respond back! So I say mid July - August
we should here a final verdict! I haven't seen any recent dilution! Just a lot of stupid trading and heavy manipulation!
For people who kept complaining about the time for IND submission time frame please click the link below and your faith in BMSN will be restored!
On Feb 5, 2013 Regen BioPharma Files Investigational New Drug (IND) Application With FDA on HemaXellerate I(TM) Stem Cell Drug for Aplastic Anemia!
This link is proof that the application as MAIL rather Electronic submission! In the link it clearly states that the application must be mailed with 3 copies of the entire submission! Which mean Koos wasn't hiding information or delaying! It takes time to get the application processed, filed then issued a reference number (IND#) Koos is operating with urgency not to please investors but to put BMSN on the right track to success!
Here the proof that eliminates all doubt!! Copy and paste this text into a search engine! I used google! >>>>>>>investigational new drug (ind) application process<<<<<<< Next look for a PDF link from the FDA! It should be the Third box down! And the link should be something like this:
www.fda.gov/downloads/.../reportsmanualsforms/forms.... Ok now download the form yourself! Scroll to the bottom of the form! If clearly has signature panel boxes as well as the panel where a FDA official would give the application an IND#!!! IND# issuance is clearly not like buy a gallon a milk at the supermarket where a receipt is given immediately! The FDA submission process is very slow for a reason! We are dealing with human life here! Have patience investors, sit back and accumulate those cheap shares while they are still here!
Last major run we had only took 1 week to reach from sub-penny level to almost .02 cents!! That's how fast BMSN moves!! We will have our day in the sun!
Now that we know for sure that we are operating in FISCAL year! Things will be very interesting in the next 30 days!! Not long before BMSN HemaXellerate receives IND status!! My honest advice BUY and HOLD!! THESE PRICES ARE GIFTS!!
FOURTH QUARTER STARTS IN JULY AND GUESS WHATS ON THE AGENDA!! BOOOMM TIME!!
Breast Cancer Technology NEWS was annouced in FEB. which mean BMSN business plan is in fiscal quarter NOT calender! This Breast Cancer news was FIRST Press Release: Bio-Matrix Scientific Group Inc. – Tue, Feb 26, 2013 10:12 AM!!! Click on the link Below and do the math yourself! FDA news can arrive at any moment! I can't believe people are confused on this issue! BMSN is not trying to confused investors! All the info is clearly laid out in black and white!
WHY WOULD MMs ALLOW THE PPS TO RISE SO SUDDENLY THINK ABOUT IT!
Upcoming Milestones Response to FDA questions: Q3 2013 Initiate HemaXellerate trial: Q4 2013 Complete HemaXellerate trial: Q4 2014-Q2 2015 In license Min technology: Q2 2013 File IND on Min technology: Q4 2013 Initiate clinical trial on Min technology: Q4 2013 Complete clinical trial on Min technology: Q4 2014-Q2 2015
Q1= OCT NOV DEC Q2= JAN FEB MAR Q3= APR MAY JUN Q4= JUL AUG SEP
BMSN IS RIGHT ON SCHEDULE!! THIS EXPLAINS WHY THE PPS MOVED UP SO SUDDENLY IN JULY! THIS IS A MAJOR CATLYST!! SECURE YOUR POSITIONS AND ENJOY THE RIDE NORTH!!
8-K for BMSN (Gene Slilencing Cancer Technology) On May 1, 2013 Dr. Wei Ping Min ("Min") entered into an agreement ("Agreement") whereby Min assigned to Regen BioPharma Inc. ("Regen") , a wholly owned subsidiary of Bio-Matrix Scientific Group, Inc.("the Company") , all right, title and interest in US Patent # 8,389,708 as well as all Patent
applications from the same family corresponding to numbers PCT/CA2006/000984, CA2612200 and EP1898936.("Min IP")
Some people here are forgetting about BMSN Business Model! There ultimate end goal is to sell the biotechnology off to Big Pharma! Even though there business approach is to see a product through Phase 1 & 2 before this happens, this “sale can come at any time!” The more Koos works on the development of these technologies such as HemaXellerate and the MIN breast cancer vaccine, the more attractive and promising it becomes to big Pharma! As investors
I wouldn't worry about funding because that can come at any moment!
OUR BUSINESS MODEL | REGEN BIOPHARMA, INC. The Regen BioPharma business model is to take multiple stem cell therapeutics to and through the human "safety and signal of efficacy" stage (Phase I/II clinical trials), followed by exit. The approach is a highly focused analysis of issued patents in regenerative medicine, identification and acquisition of undervalued assets that have demonstrated proof of concept, and forming companies around these assets. Having assembled a core infrastructure specialized in obtaining regulatory approval and executing clinical trials in cell therapy, we aim to act as a "superincubator" that within 1-2 years grows technologies from laboratory to an asset ready for spin-off or sale to feed the pipeline of Big Pharma.
Davis Koos now controls all three entities: Bio-Matrix Scientific Group, Regen BioPharma, Entest BioMedical according to recent developments announced in the 8-k release! Merging these entities is only logical from a business stand point!
BMSN has thus far stayed current with their filings and business timeline! Keep in mind investors that these future event are guides! Anything can happen especially with the FDA at any given notice! Expect a sudden rise in PPS with no reason before that news hits the wire! Given 4 straight weeks of a down trend BMSN is ready to burst out like a soda bottle being shaking up will all the wacky selling pressure! It will run hard and many will chase the PPS fast with 900% plus gains! I don't know any investor or trader that likes chasing unless your the savvy one that has been accumulation during the shouts of doom and gloom ; Sky is falling messages! This is obviously the bottom! I was hoping to get some in the .001s but that will never happen! The stock after weeks of churning has now become BULLISH! Mark this post BMSN will run hard!
PSTI received orphan drug designation for aplastic anemia which is the same disease HemaXellerate is treating! Its only in due time before HemaXellerate receives orphan drug designation!
Look at the share price the CEO purchased at!! You don't have to worry about shares being dumped on investors with no agenda other than going into a CEOs pocket, no employees, 1 trillion shares and no agenda!! BMSN is nothing like that! Its the real deal! Most of the shares purchased by the CEOs were brought well over .50!! Have no worries investors!
The key is to be patient and accumulate! That's how the PPS bounced to almost .02 in such a short time! Change your trading strategy on this one! Everyone need to be on accord here! Unless you like chasing! To each his own...Happy Trading! GLTA!
News 
Market Data 
Discover 
